![ECOG-ACRIN logo[19516]275×75](https://blog-ecog-acrin.org/wp-content/uploads/2021/03/ECOG-ACRIN-logo19516275x75.png)
March 30, 2026
The co-chairs reflect on the rapidly evolving definition of sensitive research data and highlight priorities for building secure data environments that sustain patient protection and public trust
March 30, 2026
This phase 3 clinical trial is evaluating a less intensive treatment approach for adults aged 75+ with early-stage melanoma
March 30, 2026
This phase 3 trial seeks to determine if there is any survival benefit from adding a fourth drug to induction therapy—and if so, in which patients
March 30, 2026
These studies aim to improve patient outcomes and well-being by examining complex interactions between patients, providers, and care delivery systems
March 30, 2026
The latest findings in breast cancer, cancer care delivery research, head and neck cancer, leukemia, and radiation therapy
March 30, 2026
Timely information about research presented at medical meetings, recognition of research leaders, and more